Record Annual Investments
Total investments of $1.8 billion in 2025, surpassing the prior record year and supporting portfolio diversification into UK care homes and SHOP.
Strong Full-Year FFO and FAD Growth
Normalized FFO per share increased 17.3% year-over-year to $1.76; normalized FAD per share increased 14.3% to $1.76 for full year 2025.
Quarterly Earnings Momentum
Q4 normalized FFO rose 42.7% sequentially to $104.1 million and normalized FAD rose 38.7% to $103.0 million; Q4 normalized FFO per share increased 17.5% to $0.47 and FAD per share increased 12.2% to $0.46.
Market Cap and Shareholder Returns
Equity market capitalization grew 61% in 2025 to $8.2 billion (after a 74% increase to $5.1 billion in 2024); 10-year total shareholder return through year-end approximately 439%.
Q4 and Early-2026 Deal Activity and Yields
Q4 investments of about $562 million (including first SHOP deal) with a blended stabilized yield of 8.8%; an additional ~$215 million closed since year-end.
Robust Pipeline
Investment pipeline of approximately $500 million (about half UK care homes, ~1/3 U.S. skilled nursing, remainder SHOP, loans and triple-net seniors), with quoted opportunities expected to be actionable within 12 months.
Liquidity and Capital Execution
Strong liquidity with ~$100 million cash on hand (as of 02/11/2026), full capacity on a $1.2 billion revolver, and $372 million gross proceeds pending from unsettled equity forward contracts under the ATM program.
Conservative Leverage and Credit Metrics
Low leverage with net debt to EBITDA of 0.7x, net debt to enterprise value of 3.7%, and fixed charge coverage ratio of 10.5x as of year end.
2026 Guidance Reflects Continued Growth
Initial FY2026 guidance: normalized FFO per share and normalized FAD per share of $1.90 to $1.95 (midpoint implies ~9.4% year-over-year increase) based on current announcements and excluding additional investments.